Acadia Pharmaceuticals | Capital De Empréstimo



Loan Capital Alterar Data
Acadia Pharmaceuticals USD 0 0 2024-12
ALKERMES USD 0 285.82M 2024-12
Alnylam Pharmaceuticals USD 1.02B 967K 2024-12
Biogen USD 4.55B 1.4M 2024-12
BioMarin Pharmaceutical USD 595.89M 1.27M 2024-12
Bristol-Myers Squibb USD 47.6B 1.07B 2024-12
Corcept Therapeutics USD 0 0 2024-12
Cytokinetics USD 645.6M 1.1M 2024-12
Eisai JPY 99.82B 9M 2024-12
Eli Lilly USD 28.53B 518.3M 2024-12
Incyte USD 33.54M 5.32M 2024-12
Intra Cellular Therapies USD 0 0 2024-12
J&J USD 30.65B 638M 2024-12
Moderna USD 39M 586M 2024-12
Neurocrine Biosciences USD 0 0 2024-12
Pfizer USD 57.4B 597M 2024-12
Prothena USD 0 0 2024-12
PTC Therapeutics USD 2.12B 179K 2024-12
Sarepta Therapeutics USD 1.14B 1.16M 2024-12
Ultragenyx Pharmaceutical USD 0 0 2024-12
Vertex Pharmaceuticals USD 112.8M 1.2M 2024-12



Acadia Pharmaceuticals Capital De Empréstimo - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Mar 2025.